4 trimestre 2012...ooiwa seika japan wo 2012152898 a1 20121115 intervet int bv nether-lands...

VTSANIDAD ANIMAL

8Vigilancia Tecnológica4º trimestre 2012

Bovino

Contenido

Ovino yCaprino

Porcino Avicultura Acuicultura

Apicultura Équidos Mascotas Varios

El Boletín de Vigilancia Tecnológica en Sani-dad Animal es el resultado del trabajo conjun-to de la Oficina Española de Patentes y Marcas (OEPM) y la Plataforma Tecnológica Española de Sanidad Animal (Vet+i), quienes han au-nado esfuerzos para ofrecer a los adheridos de Vet+i y a cualquier interesado en sanidad animal, una información puntual, esquemáti-ca y de rápida lectura sobre las últimas paten-tes publicadas en este campo.

Este octavo número recoge una selección de las solicitudes de patentes publicadas a nivel internacional durante el cuarto trimestre de 2012 en el ámbito de la sanidad animal, las cuales aparecen distribuidas según la especie animal de aplicación de las mismas. Asimis-mo, se incorpora un capítulo que recoge soli-citudes de patentes sobre tecnologías de apli-

cación general y contiene un apartado de enlaces a noticias de interés en materia de propiedad industrial, así como sobre las ac-tividades de la Plataforma.

El boletín, que tiene una periodicidad trimes-tral, se enmarca dentro del convenio de co-laboración suscrito por ambas organizacio-nes para facilitar, impulsar y estimular el conocimiento y la utilización de los derechos de Propiedad Industrial por parte de las or-ganizaciones y empresas adheridas a la Pla-taforma Vet+i.

Se puede acceder al listado de solicitudes de patentes para cada grupo pulsando sobre las imágenes que aparecen a continuación.

1 VTBovino

12

Nº de publicación Solicitante País de origen Contenido Técnico

BR PI0701760 A2 20090303

Seixas Adriana Brazil Cysteine protease or pep-tide derivatives for immu-nizing against tick and for use as vaccine, is obtained by extracting egg, larvae and other stages of ticks

Masuda Aoi BrazilTermignoni Carlos Brazil

Da Silva Vaz Itabajara Jr Brazil

AU 2011201420 A1 20121018 Omnigen Res Llc Australia

Beta-1,3(4)-endogluca-nohydrolase, beta-1,3(4) glucan, diatomaceous ear-th, mineral clay and gluco-mannan to modulate gas-trointestinal genes

CN 102600304 A 20120725

Univ Northwest A&F ChinaNanoemulsion composition for treating mycoplasma pneumonia of livestock and preparation method of nanoemulsion composition

Guo J ChinaOuyang S China

Ouyang W China

CN 102600307 A 20120725 Jiang Y China

Topical Chinese medicinal composition for treating Weil’s disease

CN 102614294 A 20120801

Ringpu (Tianjin) Biomedi-cal Co Ltd China Compound amoxicillin

suspension injection used for treating livestock and poultry diseases and trea-ting bacterial disease com-prises amoxicillin, cordate Houttuynia oil, suspending agent, dispersant, antioxi-dant, and plant oil for in-jection

Chang L China Nie L China

Wei D China

EP 2497479 A1 20120912

Inst Getreideverarbeitung Germany Extracts from phototropic microorganisms as adju-vantsRipac Labor Gmbh Germany

KR 20120035447 A 20120416 Eagle Vet Tech Co Ltd South

Korea

Composite for curing and preventing coccidium and producing method thereof

http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=BR&NR=PI0701760A2&KC=A2&date=&FT=D&local=en_V3


http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=AU&NR=2011201420A1&KC=A1&date=&FT=D&local=en_V3




http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=CN&NR=102600307A&KC=A&date=&FT=D&local=en_V3






http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=KR&NR=20120035447A&KC=A&date=&FT=D&local=en_V3


13


RU 2448705 C1 20120427

Federal Noe G Obrazo-vatel Noe Uchrezhdenie Vysshego Professional

Nogo Obrazovanija Orlo-vskij G Agrar

RussianFederation

Method for prevention of mastitis in cows

WO 2012150520 A1 20121108

Pfizer USA

Novel cephalosporins use-ful as antibacterial agents

Duclos Brian A USAEllsworth Edmund L USA

Ewin Richard A USAJohnson Paul D USA

Johnson Timothy A USAKyne Graham M USA

Sheehan Susan M K USAVairagoundar Rajendran USA

WO 2012124688 A1 20120920

Univ Hokkaido Nat Univ Corp Japan

Vector for pulmonary deli-very, inducing agent, and uses

Taiho Pharmaceutical Co Ltd Japan

Kusumoto Kenji JapanHarashima Hideyoshi Japan

Akita Hidetaka JapanHatakeyama Hiroto Japan

Ishitsuka Taichi Japan

CN 102533663 A 20120704 Ind Tech Res Inst China

Foot-and-mouth disease hybridoma cell line, mono-clonal antibody, detection reagent and kit

WO 2012142523 A2 20121018

Gilead Sciences Inc USA

1’-substituted pyrimidine n-nucleoside analogs for antiviral treatment

Cho Aesop USAKim Choung U USA

Kirschberg Thorsten A USAMish Michael R USA

Squires Neil USA

WO 2012144519 A1 20121026

Idemitsu Kosan Co JapanGranules in liquid dosage formIto Shinji Japan

Ooiwa Seika Japan

WO 2012152898 A1 20121115

Intervet Int Bv Nether-lands

Treatment of mastitis

Sa De Carlos FranceIlg Thomas Simon Germany

Pere Karine FranceCox Peter Gerardus Fran-

ciscus France

Warrass Ralf Germany

http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=RU&NR=2448705C1&KC=C1&date=&FT=D&local=en_V3


http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2012150520A1&KC=A1&date=&FT=D&local=en_V3












14


WO 2012142513 A1 20121018

Epizyme Inc USA

Substituted benzene com-pounds

Eisai Co Ltd JapanKuntz Kevin Wayne USAChesworth Richard USA

Duncan Kenneth William USAKeilhack Heike USA

Warholic Natalie USAKlaus Christine USAZheng Wanjun USA

WO 2012122586 A1 20120920

Phosphagenics Ltd Australia

New compositionMastitis Man Australia Pty

Ltd Australia

Libinaki Roksan AustraliaNeely Robert Lee Australia

WO 2012161558 A1 20121129

Sunzen Lifesciences Sdn Bhd Malaysia Mixtures of acids for use as

antiviral agentsKok Poe Chu Malaysia

WO 2012162471 A2 20121129

Biortec Llc USA Pachycereus plant extract and methods of use the-reofJordan-Hernandez Jose L Mexico

US 2012258127 A1 20121011 Graham Simon Paul USA Vaccine peptides

CN 102579364 A 20120718

Univ Hebei Science & Tech China

Sustained or controlled re-lease microsphere of val-nemulin/valnemulin salts and preparation method thereof

CN 102579582 A 20120718 Tiezhong Zhou China

Application of magnolia to-tal phenol in medicament for treating cow mastitis

CN 102579662 A 20120718

Guangdong Zijin Zheng-tian Pharmaceutical Co

LtdChina

Medicinal composition for treating dairy cattle mam-mitis

CN 102580068 A 20120718

Ningxia Vocational Tech-nology College China

Compound perfusate for treating mammitis of dairy cattle and preparation me-thod thereof

JP 2012188409 A 20121004

Biofermin Seiyaku Kk Japan Agent useful for e.g. pre-venting or alleviating di-gestive tract pain, prefera-bly digestive tract pain due to irritable bowel syndrome in mammals e.g. human, comprises lactic acid bac-teria, preferably Strepto-coccus or Bifidobacterium

Ono H Japan Shimakawa M Japan Tsunemine S Japan

Yamamura H Japan









http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=2012258127A1&KC=A1&date=&FT=D&local=en_V3










http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=JP&NR=2012188409A&KC=A&date=&FT=D&local=en_V3


5


WO 2012157699 A1 20121122

Ajinomoto Kk Japan

Immunostimulant for ani-mals, feed containing same, and method for ma-nufacturing same

Tokura Mitsunori JapanFudo Ryosuke Japan

Onishi Norimasa JapanEbisawa Makoto JapanKojima Junichiro JapanOota Yasuhiro Japan

Fujieda Takeshi Japan

WO 2012141540 A2 20121018

Cj Cheiljedang Corp South Korea

Novel isolated lactobacillus fermentum strain having viral infection inhibitory activity

Yang Si Yong South Korea

Lee Hyun Jeong South Korea

Woo Seo Hyung South Korea

Yeo Jung Min South Korea

WO 2012142529 A2 20121018

Genelux Corp USA

Clonal strains of attenua-ted vaccinia viruses and methods of use thereof

Szalay Aladar A USAChen Nanhai George USA

Yu Yong A USAZhang Qian USA

WO 2012142529 A3 20121206

Genelux Corp USA




WO 2012154271 A2 20121115

Kineta Inc USA Method and cells for identifying rig-i pathway regulators

Iadonato Shawn P USABedard Kristin USA

WO 2012131341 A2 20121004

Univ Manchester USA

Tight junctions modulatorsO’neill Catherine Anne United Kingdom

Gibbs Neil Kerslake United Kingdom

RU 2010119831 A 20111127

Medsintez Plant Llc RussianFederation

Use of sodium salt 2-me-thylthio-6-nitro-1,2,4-tr iazole(5,1c)-1,2,4-tr triazine-7-one dihydrate, as an antiviral agent for preventing and trea-ting acute infectious di-seases and conditions

Petrov A Yu Russian-Federation













http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=RU&NR=2010119831A&KC=A&date=&FT=D&local=en_V3


6


RU 2010131315 A 20120210

Animals Health Protection Federal Cent

RussianFederation

A 2045/kyrgyzstan/ 2007 strain of foot-and-mouth disease virus aphtae epi-zooticae type a for anti-genic and immunogenic performance control of foot-and-mouth disease vaccines and for produc-tion of biopreparations for diagnosis and spe-cific prevention of foot-and-mouth disease type a

Belik E V RussianFederation

Borisov V V RussianFederation

Jurchishin V D RussianFederation

Kamalova N E RussianFederation

Kremenchugskaya S R RussianFederation

Lezova T N RussianFederation

Mikhalishin D V RussianFederation

Mikhalishin V V RussianFederation

WO 2012117216 A1 20120907

Univ Aberdeen United Kingdom

N- (arylalkyl) - 1h- indo-le- 2 - sulfonic acid amide compounds and their the-rapeutic use as cannabi-noid allosteric modulators

Greig Lain Robert United Kingdom

Ross Ruth Alexandra United Kingdom

Pertwee Roger Guy United Kingdom

Trembleau Laurent Alain Claude

United Kingdom

Abdel-Rahman Mostafa Hamed

United Kingdom

Baillie Gemma Louise United Kingdom

WO 2012136691 A1 20121011

Aeterna Zentaris Gmbh Germany

Pyridopyrazine derivatives and their use

Gerlach Matthias GermanySeipelt Irene Germany

Blumenstein Lars GermanyMueller Gilbert Germany

Guenther Eckhard GermanySchuster Tilmann Germany

Teifel Michael Germany







247


WO 2012131134 A1 20121004

Consejo Superior Investi-gacion Spain

Use of a non-coding region of the genome of the Foot-and-mouth virus for the purpose of producing an antiviral drug

Fundacio Ct De Recerca En Sanitat Animal Cresa Spain

Inst Nac Investigacion Inia Spain

Saiz Zalabardo Margarita SpainSobrino Castello Francis-

co Spain

Borrego Rivero Belen SpainRodriguez Pulido Miguel

Ramon Spain

Saiz Calahorra Juan Car-los Spain

Martin Acebes Miguel Angel Spain



1 VTOvino y Caprino

18


CN 102600304 A 20120725

Univ Northwest A&F China Nanoemulsion composi-tion for treating myco-plasma pneumonia of livestock and preparation method of nanoemulsion composition


Ouyang W China

CN 102614294 A 20120801

Ringpu (Tianjin) Biomedi-cal Co Ltd China Compound amoxicil-

lin suspension injection used for treating livestock and poultry diseases and treating bacterial disease comprises amoxicillin, cordate Houttuynia oil, suspending agent, dis-persant, antioxidant, and plant oil for injection


Wei D China

EP 2497479 A1 20120912

Inst Getreideverarbeitung GermnayExtracts from phototropic microorganisms as adju-vantsRipac Labor Gmbh Germnay

RU 2010131315 A 20120210


RussianFederation

A 2045/kyrgyzstan/ 2007 strain of foot-and-mouth disease virus aphtae epi-zooticae type a for anti-genic and immunogenic performance control of foot-and-mouth disease vaccines and for produc-tion of biopreparations for diagnosis and specific prevention of foot-and-mouth disease type a

Belik E V RussianFederation

Borisov V V RussianFederation

Jurchishin V D RussianFederation

Kamalova N E RussianFederation

Kremenchugskaya S R RussianFederation

Lezova T N RussianFederation

Mikhalishin D V RussianFederation

Mikhalishin V V RussianFederation





http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=EP&NR=2497479A1&KC=A1&date=&FT=D&local=en_V3




19


WO 2012150520 A1 20121108

Pfizer USA






WO 2012117216 A1 20120907


N- (arylalkyl) - 1h- in-dole- 2 - sulfonic acid am-ide compounds and their therapeutic use as canna-binoid allosteric modula-tors





United Kingdom


United Kingdom


WO 2012152898 A1 20121115

Intervet Int Bv N e t h e r -lands

Treatment of mastitis

Sa De Carlos FranceIlg Thomas Simon Germany

Pere Karine FranceCox Peter Gerardus Fran-

ciscus France

Warrass Ralf Germany

WO 2012136691 A1 20121011







WO 2012142513 A1 20121018

Epizyme Inc USA















110


WO 2012122586 A1 20120920



Ltd Australia


WO 2012161558 A1 20121129

Sunzen Lifesciences Sdn Bhd Malaysia Mixtures of acids for use

as antiviral agentsKok Poe Chu Malaysia

WO 2012162471 A2 20121129

Biortec Llc USA Pachycereus plant extract and methods of use there-ofJordan-Hernandez Jose L Mexico

US 2012258127 A1 20121011 Graham Simon Paul USA Vaccine peptides

CN 102579364 A 20120718 Univ Hebei Science & Tech China

Sustained or controlled release microsphere of va lnemul in/va lnemu-lin salts and preparation method thereof

CN 102580075 A 20120718

Guizhou Inst Of Animal And Veterinary China

Divalent combined oil-emulsion inactivated vac-cine for preventing goat contagious pleuropneu-monia and preparation method

WO 2012142529 A2 20121018

Genelux Corp USA

Clonal strains of attenu-ated vaccinia viruses and methods of use thereof



WO 2012142529 A3 20121206

Genelux Corp USA




KR 20110119975 A 20111103

Korea Res Inst Chem Technology

South Korea

Composition comprising 3-(4-methoxybenzylami-nomethylene) -1,3-dihy-droindol-2-one(5-108) for preventing and treating the disease caused by toxo-plasmosis and coccidium

Univ Wonkwang Cent Ind Acad Coop

South Korea

Chun M J South Korea

Han Y J South Korea

Kim S South Korea

Kim S Y South Korea

Lee K I South Korea

Park H South Korea

















http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&II=0&ND=3&adjacent=true&locale=es_LP&FT=D&date=20111103&CC=KR&NR=20110119975A&KC=A


111


WO 2012154271 A2 20121115

Kineta Inc USA Method and cells for iden-tifying rig-i pathway regu-lators


WO 2012144519 A1 20121026

Idemitsu Kosan Co JapanGranules in liquid dosage formIto Shinji Japan

Ooiwa Seika Japan

WO 2012157699 A1 20121122

Ajinomoto Kk Japan

Immunostimulant for animals, feed containing same, and method for manufacturing same




WO 2012131341 A2 20121004

Univ Manchester United Kingdom

Tight junctions modula-torsO’neill Catherine Anne United

Kingdom



Beta-1,3(4)-endoglucano-hydrolase, beta-1,3(4) glucan, diatomaceous earth, mineral clay and glucomannan to modulate gastrointestinal genes

RU 2010119831 A 20111127

Medsintez Plant Llc RussianFederation

Use of sodium salt 2-me-thylthio-6-nitro-1,2,4-triazole(5,1c)-1,2,4-tr triazine-7-one dihydrate, as an antiviral agent for preventing and treat-ing acute infectious dis-eases and conditions

Petrov A Yu Russian Federation

WO 2012124688 A1 20120920


Vector for pulmonary de-livery, inducing agent, and uses























1 VTPorcino

12



Beta-1,3(4)-endoglucano-hydrolase, beta-1,3(4) glucan, diatomaceous earth, mineral clay and glucomannan to modulate gastrointestinal genes

US 2012295886 A1 20121122 Influmedix Inc USA Antiviral compounds and

their methods of use

CN 102614294 A 20120801


lin suspension injection used for treating livestock and poultry diseases and treating bacterial dis-ease comprises amoxicil-lin, cordate Houttuynia oil, suspending agent, dispersant, antioxidant, and plant oil for injection


Wei D China

EP 2497479 A1 20120912


RU 2010119831 A 20111127

Medsintez Plant Llc Russian Federation

Use of sodium salt 2-methyl th io-6-ni t ro-1 ,2 ,4- t r i azo le (5 ,1c ) -1,2,4-tr triazine-7-one dihydrate, as an antiviral agent for preventing and treating acute infectious diseases and conditions

Petrov A Yu Russian Federation











13


RU 2010131315 A 20120210


Russian Federation

A 2045/kyrgyzstan/ 2007 strain of foot-and-mouth disease virus aphtae epi-zooticae type a for anti-genic and immunogenic performance control of foot-and-mouth disease vaccines and for produc-tion of biopreparations for diagnosis and specific prevention of foot-and-mouth disease type a

Belik E V Russian Federation

Borisov V V Russian Federation

Jurchishin V D Russian Federation

Kamalova N E Russian Federation

Kremenchugskaya S R Russian Federation

Lezova T N Russian Federation

Mikhalishin D V Russian Federation

Mikhalishin V V Russian Federation

WO 2012124688 A1 20120920


Vector for pulmonary de-livery, inducing agent, and uses





CN 102552369 A 20120711

Jianfeng Chen China lon icera japonica thunb leaf extractive serving as anti-porcine reproductive and respiratory syndrome viral agent

Kun Zou China

CN 102552896 A 20120711

Tianjin Ringpu Bio Tech-nology Co Ltd China

Preparation method of porcine reproductive and respiratory syndrome vac-cines by utilizing bioreac-tor

CN 102532309 A 20120704

Univ Huazhong Agricul-tural China Colloid gold test strip for

detecting porcine repro-ductive and respiratory syndrome antibody

Wuhan Keqian Animal Bio-log Products Co Ltd China















14


WO 2012142513 A1 20121018

Epizyme Inc USA





WO 2012161558 A1 20121129

Sunzen Lifesciences Sdn Bhd Malaysia Mixtures of acids for use

as antiviral agentsKok Poe Chu Malaysa

WO 2012162471 A2 20121129

Biortec Llc USA Pachycereus plant extract and methods of use there-ofJordan-Hernandez Jose L Mexico

WO 2012163258 A1 20121206

Sinovet Beijing Biotech-nology Co Ltd China

Combined vaccines for prevention of porcine virus infections

Wu Hua ChinaHe Yanliang ChinaXia Mingqi China

WO 2012163263 A1 20121206

Sinovet Beijing Biotech-nology Co Ltd China

Reagents and methods for prrsv detectionWu Hua China

Liu Zhun ChinaUS 2012258127 A1

20121011 Graham Simon Paul USA Vaccine peptides

WO 2012166493 A1 20121206

Merial Ltd USA

Needle-free administra-tion of prrsv vaccines

Chulalongkorn University ThailandSuradhat Sanipa Thailand

Audonnet Jean-Christophe FranceCharreyre Catherine France

CN 102559614 A 20120711

Tianjin Yaoyu Biotechnol-ogy Co Ltd China

Classical swine fever vac-cine and preparation method thereof

CN 102559816 A 20120711 Jianbao Han China

Preparation method of an-tibacterial lipopeptide and application thereof to vet-erinary medicine

CN 102580076 A 20120718

Genifarm Guangzhou Technology Inc China

Synthetic peptide vaccine for o-type foot and mouth disease of swine and prep-aration method thereof





















115


WO 2012141540 A2 20121018

Cj Cheiljedang Corp South Korea

Novel isolated lactobacil-lus fermentum strain hav-ing viral infection inhibi-tory activity

Yang Si Yong South Korea

Lee Hyun Jeong South Korea

Woo Seo Hyung South Korea

Yeo Jung Min South Korea

WO 2012153160 A1 20121115

Avi Mex S A De C V Lab Mexico

Recombinant vaccine against prrs in a viral vec-tor

Lozano-Dubernard Ber-nardo Mexico

Soto-Priante Ernesto MexicoSarfati-Mizrahi David Mexico

Lara-Puente Jesus Horacio Mexico

WO 2012142529 A2 20121018

Genelux Corp USA




WO 2012142529 A3 20121206

Genelux Corp USA




US 2012244191 A1 20120927 Alpharma Llc USA

Compositions and meth-ods for controlling diseas-es in animals

CN 102600304 A 20120725

Univ Northwest A&F China Nanoemulsion composi-tion for treating mycoplas-ma pneumonia of livestock and preparation method of nanoemulsion composition


Ouyang W China

WO 2012150520 A1 20121108

Pfizer USA






CN 102579364 A 20120718 Univ Hebei Science & Tech China

Sustained or controlled release microsphere of va lnemu l in /va lnemu-lin salts and preparation method thereof

















116


KR 20120035447 A 20120416 Eagle Vet Tech Co Ltd South

Korea

Composite for curing and preventing coccidium and producing method thereof

WO 2012157699 A1 20121122

Ajinomoto Kk Japan

Immunostimulant for animals, feed contain-ing same, and method for manufacturing same




WO 2012154271 A2 20121115



WO 2012131341 A2 20121004

Univ Manchester United Kingdom

Tight junctions modula-tors

O’neill Catherine Anne United Kingdom


WO 2012117216 A1 20120907


N- (arylalkyl) - 1h- indole- 2 - sulfonic acid amide compounds and their ther-apeutic use as cannabi-noid allosteric modulators





United Kingdom


United Kingdom


WO 2012136691 A1 20121011







WO 2012122586 A1 20120920



Ltd Australia
















2417


KR 20110119975 A 20111103

Korea Res Inst Chem Tech-nology

South Korea



South Korea

Chun M J South Korea

Han Y J South Korea

Kim S South Korea

Kim S Y South Korea

Lee K I South Korea

Park H South Korea

JP 2012188409 A 20121004

Biofermin Seiyaku Kk Japan Agent useful for e.g. pre-venting or alleviating di-gestive tract pain, prefer-ably digestive tract pain due to irritable bowel syndrome in mammals e.g. human, compris-es lactic acid bacteria, preferably Streptococ-cus or Bifidobacterium


Yamamura H Japan

WO 2012131134 A1 20121004

Consejo Superior Inves-tigacion Spain



Inst Nac Investigacion Inia SpainSaiz Zalabardo Margarita SpainSobrino Castello Francisco Spain


Ramon Spain

Saiz Calahorra Juan Carlos SpainMartin Acebes Miguel An-

gel Spain







1 VTAvicultura

18


CN 102600383 A 20120725

Heilongjiang Huifeng Ani-mal Healthcare F China Chinese medicinal herb

preparation, e.g. for elimi-nating pathogens to sup-port healthy Qi of poul-try, comprises Echinacea purpurea, honeysuckle, licorice, folium isatidis, bal-loonflower, Lophatherum gracile, mint, and hypericin

Qingdao Keyahua Animal Pharm Co Ltd China

Liang H; ChinaTang J ChinaYin J; China

Zhao F China

CN 102614288 A 20120801

Zhengzhou Houyi Pharm Co Ltd China Chinese herbal micro-

ecological preparation for preventing and treating chicken Colibacillosis and preparation method there-of

Li F ChinaLi J China

Wu H China

CN 102617732 A 20120801

Guangdong Zijin Zheng-tian Pharm Co Ltd China

Novel egg yolk antibody and preparation method for same

Li Z ChinaLiu Y China

Wang Q China

RU 2454995 C1 20120710

G Nauchnoe Uchrezhdenie Gnu Vrnii Gel Mintologii Im

K I Skrjabina Vigis

Russian Fed e ra -

tion

Method for disinvasion from avian coccidian oo-cysts

WO 2012131731 A1 20121004 Oinam Ibetombi Devi India A herbal formulation to

treat coccidiosis

CN 102552477 A 20120711

Tianjin Rebate Science & Technology Dev Co Ltd China

Traditional chinese medici-nal composition for treat-ing chicken coccidiosis and preparation method there-of

CN 102552600 A 20120711

Baoding Jizhong Pharma-ceutical Co Ltd China

Traditional chinese medi-cine for preventing and treating chicken infectious laryngotracheitis and pro-duction method thereof

CN 102552641 A 20120711

Beijing Vocational College Of Agriculture China

Chinese herbal medicine formula for preventing and treating broiler colibacillo-sis

















19


CN 102533618 A 20120704 Univ Jiangnan China

Lactobacillus plantarum ccfm8724 and application thereof

CN 102584994 A 20120718

Guangdong Zijin Zheng-tian Pharmaceutical Co Ltd China

Egg yolk antibody for cur-ing colibacillosis and prep-aration method thereof

CN 102586166 A 20120718

Yebio Bioengineering Co Ltd Of Qingdao China

Construction of recombi-nant bacteria expressing avian encephalomyelitis vi-rus vp1 protein

CN 102586194 A 20120718

Harbin Pharmaceutical Group Bio Vaccine Co Ltd China

H9 subtype avian influ-enza virus vero cell adapt-ed strain and application thereof

WO 2012160183 A1 20121129

Intervet Int Bv Ne t he r -lands

Immunostimulatory oligo-deoxynucleotidesSchrier Carla Christina Ne t h e r -

landsIlg Thomas Simon Germany

WO 2012160184 A1 20121129

Intervet Int Bv Ne t he r -lands

Immunostimulatory oligo-deoxynucleotidesSchrier Carla Christina Ne t h e r -

landsIlg Thomas Simon Germany

WO 2012131134 A1 20121004

Consejo Superior Inves-tigacion Spain





Ramon Spain


gel Spain

WO 2012157699 A1 20121122

Ajinomoto Kk Japan

Immunostimulant for animals, feed contain-ing same, and method for manufacturing same




















120


CN 102559610 A 20120711

Harbin Veterinary Res Inst Caas China

Recombined duck virus en-teritis viral vaccine strain cctcc for expressing bird flu virus hemagglutinin (ha) gene (rdevus78ha) as well as establishing method and application thereof

CN 102559816 A 20120711 Jianbao Han China

Preparation method of an-tibacterial lipopeptide and application thereof to vet-erinary medicine

CN 102579339 A 20120718

Tianjin Ringpu Biolog Pharmaceutical Co Ltd China

Oil emulsion vaccine for broilers and preparation method thereof

CN 102579606 A 20120718

Ringpu Tianjin Bio Phar-macy Co Ltd China

Anticoccidial traditional chinese medicine prepara-tion and preparation meth-od thereof

CN 102579647 A 20120718

Qingdao Lvman Biolog En-gineering Company China

Chinese medicinal oral liq-uid for treating escherichia coli disease of poultry, and its preparation method

CN 102579697 A 20120718

Guizhou Inst Of Animal And Veterinary China

Chinese herbal prescription for treating coccidiosis in chicken

CN 102579992 A 20120718

Changshu Huagang Phar-maceutical Co Ltd China

Traditional chinese medi-cine feed additive capable of effectively preventing and treating blackhead dis-ease in chickens

JP 2012180304 A 20120920

Biseibutsu Kagaku Kenkyusho Kk

Japan Drink for controlling campy-lobacter infection of chicken

Kaneshige T Japan

US 2012245082 A1 20120927

Lillehoj Hyun Soon USA Novel antimicrobial activ-ity of chicken nk-2 peptide against apicomplexan pro-tozoa

Lee Sung Hyen USA

Hong Yeong Ho SouthKorea

WO 2012141540 A2 20121018

Cj Cheiljedang Corp SouthKorea

Novel isolated lactobacil-lus fermentum strain hav-ing viral infection inhibitory activity

Yang Si Yong SouthKorea

Lee Hyun Jeong SouthKorea

Woo Seo Hyung SouthKorea

Yeo Jung Min SouthKorea





















121


US 2012244191 A1 20120927 Alpharma Llc USA

Compositions and methods for controlling diseases in animals

WO 2012129645 A1 20121004

Univ Guelph Canada

Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof

Nagy Eva CanadaGriffin Bryan CanadaGrgic Helena CanadaOjkic Davor Canada

RU 2465313 C2 20121027

Rossijskaja Akademija Sel Skokhozjajstvennykh Nauk Raskhn G Nauchnoe Uchrezhdenie Vserossijskij

Ni V

RussianFed e ra -

tion

Chicken coccidiosis (eumeriosis) vaccine

CN 102600120 A 20120725

Univ China Agric China Application of cinnamic acid in preparation of drugs for preventing and treating livestock and poultry virus infection

He C ChinaOu C China

Pan Q China

CN 102600304 A 20120725

Univ Northwest A&F China Nanoemulsion composition for treating mycoplasma pneumonia of livestock and preparation method of na-noemulsion composition


Ouyang W China

CN 102641261 A 20120822

Veterinary Res Inst Guang-dong Agric Sci China

Application of Vorinostat in preparation of soft-resis-tant Eimeria drugs

Liao S ChinaLv M ChinaQi N China

Sun M ChinaWen L ChinaWu C ChinaXie M China

CN 102614294 A 20120801


lin suspension injection used for treating livestock and poultry diseases and treating bacterial dis-ease comprises amoxicil-lin, cordate Houttuynia oil, suspending agent, dispersant, antioxidant, and plant oil for injection


Wei D China

EP 2497479 A1 20120912


















2522


PL 391994 A1 20120130 Inst Biochemii I Biofizyki Poland

Gene encoding the heter-ologous protein of the avi-an influenza virus hemag-glutinin, a gene encoding a heterologous protein of chicken interleukin-second (chile-2), a method for obtaining these genes, a strain of lactic acid bacteria containing this gene/these genes, application thereof, immunogenic composition, a vaccine against avian in-fluenza and the nucleotide sequence of the promoter region pf ptcb gene

CN 102552893 A 20120711 Univ Jilin China

Chicken eimeria tenella ac-tin depolymerizing factor (adf) recombinant bacillus calmette-guerin and prep-aration method thereof

KR 20120090188 A 20120817 Jang Doo Soon South

Korea

Pharmaceutical composite for preventing or treating of avian influenza infection, and method for preventing or treating of avian influen-za infection by using thereof

KR 20120098351 A 20120905

Univ Sungkyunkwan Res & Bus

SouthKorea

A composition for prevent-ing bird flu comprising in-terferon receptor gene

KR 20120098350 A 20120905

Univ Sungkyunkwan Res & Bus

SouthKorea

A composition for prevent-ing bird flu comprising in-terferon receptor gene

KR 20110130591 A 20111206 Yank Sung INC South

KoreaComposition for preventing chicken contagious disease

WO 2012142529 A2 20121018

Genelux Corp USA




WO 2012142529 A3 20121018

Genelux Corp USA




http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=PL&NR=391994A1&KC=A1&date=&FT=D&local=en_V3

http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=PL&NR=391994A1&KC=A1&date=&FT=D&local=en_V3



http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20120817&CC=KR&NR=20120090188A&KC=A


http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20120905&CC=KR&NR=20120098351A&KC=A

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20120905&CC=KR&NR=20120098351A&KC=A









23


WO 2012142513 A1 20121018

Epizyme Inc USA





WO 2012154271 A2 20121115

Kineta Inc USA Method and cells for identi-fying rig-i pathway regula-tors





Beta-1,3(4)-endoglucano-hydrolase, beta-1,3(4) glu-can, diatomaceous earth, mineral clay and gluco-mannan to modulate gas-trointestinal genes

WO 2012117216 A1 20120907

Univ Aberdeen UnitedKingdom

N- (arylalkyl) - 1h- indole- 2 - sulfonic acid amide compounds and their ther-apeutic use as cannabinoid allosteric modulators

Greig Lain Robert UnitedKingdom

Ross Ruth Alexandra UnitedKingdom

Pertwee Roger Guy UnitedKingdom


UnitedKingdom


UnitedKingdom

Baillie Gemma Louise UnitedKingdom

KR 20110119975 A 20111103

Korea Res Inst Chem Tech-nology

SouthKorea



SouthKorea

Chun M J SouthKorea

Han Y J SouthKorea

Kim S SouthKorea

Kim S Y SouthKorea

Lee K I SouthKorea

Park H SouthKorea













1 VTAcuicultura

24


US 2012258138 A1 20121011

Univ Idaho Board Of Re-gents USA

Probiotic bacterial strains and method of use to de-crease mortality in fish due to bacterial disease

CN 102586144 A 20120718

South China Sea Inst Oceanolog China

Bacillus pumilus, probiotics preparation and prepara-tion method and applica-tion thereof

WO 2012143488 A1 20121026


Protein for use as a medi-cament

West Van Pieter UnitedKingdom

Secombes Christopher John

UnitedKingdom

Anderson Victoria Louise UnitedKingdom

Minor Kirsty Louise UnitedKingdom

WO 2012162471 A2 20121129

Biortec Llc USA Pachycereus plant extract and methods of use thereofJordan-Hernandez Jose L Mexico

WO 2012157699 A1 20121122

Ajinomoto Kk Japan




Fujieda Takeshi JapanUS 2012301534 A1

20121129 Univ Nat Cheng Kung Taiwan Method for lowering feed conversion rate

US 2012276054 A1 20121101

Williams Henry N USAAlternative bacterial treatmentGulig Paul A USA

Chen Huan USA

WO 2012149549 A2 20121101

Univ Auburn USABacillus bacteria for use in treating and preventing in-fection in aquatic animals

Terhune Jeffery USALiles Mark USA

Kloepper Joseph USA

















2525


US 2012244190 A1 20120927

Shoemaker Craig A USA Vaccination of sex reversed hybrid tilapia (oreochromis niloticus x o. aureus) with an inactivated vibrio vulni-ficus vaccine

Lafentz Benjamin R USA

KR 20120104803 A 20120924

Jeong Chang Hwa SouthKorea Anti-bacterial compositions

against fish pathogenic bacteria comprising ex-tracts of terminaliachebula retzius, galla rhois and le-mongrass

Kim Moo Sang SouthKorea

Kim Seong Mi SouthKorea

KR 20120063245 A 20120615

Kang So Young SouthKorea

Anti-bacterial and anti-protozoal composition con-taining bromophenol deri-vatives

Jung Sung Ju SouthKorea

Lee Sang Yun SouthKorea

Choi Jun Ho SouthKorea

KR 20110119975 A 20111103

Korea Res Inst Chem Te-chnology

SouthKorea



SouthKorea

Chun M J SouthKorea

Han Y J SouthKorea

Kim S SouthKorea

Kim S Y SouthKorea

Lee K I SouthKorea

Park H SouthKorea









1 VTApicultura

26

No hay referencias este trimestre

1 VTÉquidos

27




EP 2497479 A1 20120912


WO 2012129330 A1 20120927

Option Pharmaceutical Llc USA Targeted cytokine for treatment of musculoske-letal diseasesLauerman Tod USA

WO 2012129562 A2 20120927

Scripps Research Inst USACompounds and methods for inducing chondrogene-sis

Shultz Peter USA

Bouchez Laure Switzer-land

US 2012252807 A1 20121004 Univ Michigan USA Arbovirus inhibitors and

uses thereof

WO 2012141540 A2 20121018


Novel isolated lactobacillus fermentum strain having viral infection inhibitory ac-tivity





WO 2012125525 A2 20120920

Boehringer Ingelheim Ve-tmed USA

Equine rhinitis vaccineHayes Phillip Wayne USAHennessy Kristina J USA

Viel Laurent CanadaDiaz-Mendez Andres Canada

WO 2012142407 A1 20121018

Topmd Inc USA

Sodium hypochlorite-based body wash compositions

Anwar Azam USACockerell Clay J USASitbon Catherine USA

















128+


WO 2012142529 A2 20121018

Genelux Corp USA




WO 2012142529 A3 20121206

Genelux Corp USA


Szalay Aladar A USAChen Nanhai George USAYu Yong A USAZhang Qian USA

WO 2012142513 A1 20121018

Epizyme Inc USA





WO 2012131341 A2 20121004

Univ Manchester UnitedKingdom

Tight junctions modulatorsO’neill Catherine Anne UnitedKingdom

Gibbs Neil Kerslake UnitedKingdom

WO 2012124688 A1 20120920







WO 2012117216 A1 20120907







UnitedKingdom


UnitedKingdom














129


WO 2012136691 A1 20121011







JP 2012188409 A 20121004



Yamamura H Japan

WO 2012131134 A1 20121004

Consejo Superior Investi-gacion Spain





Ramon Spain


gel Spain







1 VTMascotas

30


EP 2497479 A1 20120912


WO 2012142407 A1 20121018

Topmd Inc USASodium hypochlorite-ba-sed body wash composi-tions

Anwar Azam USACockerell Clay J USASitbon Catherine USA

WO 2012130970 A1 20121004

Nestec Sa Switzer-land

Natural derivative of the lactobacillus johnsonii strain cncm i-1225 defi-cient in d-lactic acid pro-duction

Pridmore Raymond-David Switzer-land

Foata Francis Switzer-land

Delley Michele Switzer-land

Jankovic Ivana Switzer-land

WO 2012142513 A1 20121018

Epizyme Inc USA













131


WO 2012152317 A1 20121115

Okapi Sciences Nv Belgium

Compounds for use in the treatment of feline retrovi-ral infections

Justa Nina GermanyHartmann Katrin GermanyDaminet Sylvie BelgiumDebille Mariella BelgiumAuwerx Joeri BelgiumGoris Nesya Belgium

Wera Stefaan BelgiumBlomsma Erwin Belgium

Billiet Aino BelgiumSwinnen Jan BelgiumVrancx Bert Belgium

Debeurme Veerle BelgiumNeyts Johan Belgium

WO 2012154271 A2 20121115



US 2012269786 A1 20121025

Woods Erik John USA Systemic, allogenic stem cell therapies for treatment of diseases in felines

Zacharias Shelly J USAThirumala Sreedhar USA

WO 2012131341 A2 20121004

Univ Manchester UnitedKingdom

Tight junctions modulatorsO’neill Catherine Anne UnitedKingdom

Gibbs Neil Kerslake UnitedKingdom

WO 2012142529 A2 20121018

Genelux Corp USA




WO 2012142529 A3 20121206

Genelux Corp USA




WO 2012129330 A1 20120927

Option Pharmaceutical Llc USA Targeted cytokine for treatment of musculoske-letal diseasesLauerman Tod USA















132


WO 2012129562 A2 20120927

Scripps Research Inst USACompounds and methods for inducing chondrogene-sis

Shultz Peter USA

Bouchez Laure Switzer-land

WO 2012157699 A1 20121122

Ajinomoto Kk Japan





WO 2012141540 A2 20121018


Novel isolated lactobacillus fermentum strain having viral infection inhibitory activity





RU 2010119831 A 20111127

Medsintez Plant Llc Russian

Fe d e ra -tion

Use of sodium salt 2-me-thylthio-6-nitro-1,2,4-triazole(5,1c)-1,2,4-tr triazine-7-onedihydrate, as an antiviral agent for preventing and trea-ting acute infectious di-seases and conditions

Petrov A Yu Russian

Fe d e ra -tion

WO 2012124688 A1 20120920

















2433

WO 2012117216 A1 20120907







UnitedKingdom


UnitedKingdom


WO 2012136691 A1 20121011




Blumenstein Lars Germany

Mueller Gilbert Germany



JP 2012188409 A 20121004



Yamamura H Japan







1 VTVarios

34


EP 2497479 A1 20120912


WO 2012142529 A2 20121018

Genelux Corp USA




WO 2012142529 A3 20121206

Genelux Corp USA




US 2012276054 A1 20121101

Williams Henry N USAAlternative bacterial treatmentGulig Paul A USA

Chen Huan USA

CN 102604992 A 20120725

Tianjin Agric College China Constructing recombinant adenovirus with tumor necrosis factor-related apoptosis-inducing ligand and hemagglutinin-neu-raminidase genes, useful for preventing neoplastic diseases in animals, com-prises connecting genes with amino acid linker

Dong D ChinaGao J ChinaJin T ChinaQin Y China Xu L China

Sun Y China

WO 2012129295 A1 20120927

Vaxin Inc USA Rapid and prolonged im-munologic-therapeuticTang De-Chu C USA

WO 2012157699 A1 20121122

Ajinomoto Kk Japan



















35


CN 102584992 A 20120718

Beijing Dabeinong Tech Group China Colon bacillus outer mem-

brane protein monoclonal antibody and preparation method and application thereof

Fuzhou Da Bei Nong Bio-tech Co Ltd China

WO 2012122629 A1 20120920

Univ Mcmaster Canada

A method of vaccination comprising a histone dea-cetylase inhibitor

Bridle Bryam CanadaLichty Brian Canada

Wan Yonghong CanadaDiallo Jean-Simon Canada

Lemay Chantal CanadaBell John Canada

WO 2012142513 A1 20121018

Epizyme Inc USA





WO 2012130968 A1 20121004

Nestec Sa Switzer-land

Natural derivative of the lactobacilus johnsonii stra-in cncm i-1225, deficient in d-lactic acid production and with a further impro-ved immune profile

Pridmore Raymond-David Switzer-land

Foata Francis Switzer-land

Delley Michele Switzer-land

Jankovic Ivana Switzer-land

WO 2012151578 A1 20121108

Baylor Res Inst USA

Immunog l o bu l i n - l i k e transcript (ilt) receptors as cd8 antagonists

Klechevsky Eynav IsraelBanchereau Jacques F USA

Zurawski Gerard USAZurawski Sandra USA



WO 2012145491 A2 20121026 Fisher Jason USA

Composition and method for enhancing an immune response









http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20121108&CC=WO&NR=2012151578A1&KC=A1

http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20121108&CC=WO&NR=2012151578A1&KC=A1





2536


WO 2012124688 A1 20120920







WO 2012161558 A1 20121129

Sunzen Lifesciences Sdn Bhd Malaysia Mixtures of acids for use as

antiviral agentsKok Poe Chu Malaysia

WO 2012117216 A1 20120907







UnitedKingdom


UnitedKingdom


WO 2012136691 A1 20121011







WO 2012122586 A1 20120920



Ltd Australia


BR PI0701760 A2 20090303

Seixas Adriana Brazil Cysteine protease or pep-tide derivatives for immu-nizing against tick and for use as vaccine, is obtained by extracting egg, larvae and other stages of ticks

Masuda Aoi BrazilTermignoni Carlos Brazil

Da Silva Vaz Itabajara Jr Brazil













2437


JP 2012188409 A 20121004



Yamamura H Japan

WO 2012162428 A1 20121129

Us Of America As Repre-sented By The Secretary Dept Of Health & Human

Services

USA

Prime-boost vaccination for viral infection

Nabel Gary J USAKo Sung-Youl USACheng Cheng USAKong Wing-Pui USA

Flatz Lukas Switzer-land





24

Noticias

Programa Iberoamericano de Propiedad Industrial y Promoción del Desarrollo

Este Programa persigue ofrecer a las PYMES, a las universidades y a los centros de investigación un ambiente integrado de promoción y protección de los derechos de PI.

38

Programa de Ayudas de la OEPM

La OEPM ha destinado durante 2012 un total de 3.991.508,43 de euros al Programa de ‘Ayudas para la protección de las innovaciones de las empresas españolas en el exterior’.

Nuevos criterios de valoración para la evaluación de la actividad científica

La CNEAI ha publicado en el BOE una resolución para la modificación de los criterios de evaluación que se deben aplicar al régimen retributivo del profesorado universita-rio.

Novedades en la OEPM

Las novedades presentadas para 2013 pasan por las tasas, formularios, publicacio-nes, folletos informativos y la publicación digital de los Modelos de Utilidad.

Concurso de Innovación de la OEP

Esta convocatoria permitirá a universidades y estudiantes utilizar la documentación de patentes y proponer nuevos campos de innovación, haciendo especial hincapié en las tecnologías verdes y de desarrollo sostenible.

Lanzamiento de CPC y nueva versión de CIP

La Oficina Europea de Patentes (OEP) y la Oficina Americana de Patentes y Marcas (USPTO) han lanzado la Cooperative Patent Classification (CPC), un sistema de clasi-ficación global para documentos de patentes.

Convenio de colaboración entre OEPM y SPEGC

Con el Convenio se establece un canal bidireccional para colaborar en la difusión de los derechos de PI y la gestión de los mismos.

Firma de Acuerdo PPH MOTTAINAI con PortugalEl pasado día 17 de enero de 2013, la Oficina Española de Patentes y Marcas (OEPM) y el Instituto Nacional de la Propiedad Industrial de Portugal (INPI-PT) firmaron en Lisboa un acuerdo bilateral PPH-Mottainai (Patent Prosecution Highway), que entrará en vigor el próximo 1 de febrero.

http://213.27.227.219/oepm/enero/noticia-04.html




http://www.oepm.es/es/sobre_oepm/noticias/2013/2013_01_18_FirmaAcuerdoPPH_MOTTAINAI_Portugal.html

http://www.oepm.es/cs/OEPMSite/contenidos/Revista_InfoPYM/2012/diciembre/castellano/diciembre/noticia-02.html



24

Noticias

39

Nuevo sistema de clasificación CPC (Cooperative Patent Classification)Este sistema es el resultado de la colaboración entre ambas oficinas, la OEP y la USPTO, en un esfuerzo conjunto para desarrollar un sistema común de clasificación internacional de documentos técnicos, en particular las publicaciones de patentes que será utilizado por ambas oficinas durante el procedimiento de concesión de patentes.

Más de 80.000 modelos de utilidad salen a la luz

La Oficina Española de Patentes y Marcas, OEPM, ha publicado digitalmente más de 80.000 modelos de utilidad solicitados entre los años 1940 y 1968.

Nuevos criterios de valoración para la evaluación de la actividad científica que inclu-ye el reconocimiento de las patentes y la transferencia del conocimiento e innova-ción: “sexenio tecnológico”La CNEAI ha publicado en el BOE una resolución para la modificación de los criterios de evaluación que se deben aplicar al régimen retributivo del profesorado universi-tario de documentos técnicos.

Participación en el Concurso de Innovación de la Oficina Europea de Patentes

Todos aquellos interesados en participar en el Concurso de Innovación (EPO Innova-tion Contest) de la Oficina Europea de Patentes (OEP) deberán presentar sus candi-daturas ante la OEPM.

Firma del Convenio de Colaboración entre la OEPM y la ITECAM, en materia de Pro-piedad IndustrialEl presente Convenio tiene como objeto establecer un marco de cooperación entre la OEPM e ITECAM, con el fin de facilitar, impulsar y estimular el conocimiento y la utilización de los derechos de Propiedad Industrial por parte de las empresas inte-gradas en la Asociación.

Ratificación del Tratado sobre el Derecho de Patentes (PLT) El Tratado, adoptado el 1 de junio de 2000, tiene por objeto la armonización de las formalidades nacionales en lo relativo a la solicitud y el mantenimiento de patentes, así como otros aspectos adicionales.

http://www.oepm.es/es/sobre_oepm/noticias/2012/2012_12_18_Concurso_Innovacion_EPO.html

http://www.oepm.es/es/sobre_oepm/noticias/2012/2012_11_20_Firma_Convenio_Metal_PI.html


http://www.oepm.es/es/sobre_oepm/noticias/2012/2012_12_21_ModelosUtilidad_digitalizados_1940_1968.html

http://www.oepm.es/es/sobre_oepm/noticias/2012/2012_12_19_NuevosCristeriosSexenioTecnologico.html

http://www.cooperativepatentclassification.org/index.html

24

Noticias

II Edición Foro Transfiere

Vet+i participará en la segunda edición de Foro Transfiere que tendrá lugar en Má-laga, los días 13 y 14 de febrero de 2013.

Jornada ‘Aportando valor a la empresa: incorporación de talento e incentivos fisca-les en I+D+i’

Esta Jornada organizada por Vet+i se celebrará el próximo 12 de febrero de 2013 en Madrid

40

Vet+i crea el Newsletter de Vetinnova

El pasado mes de diciembre, Vet+i lanzó “Novedades Vetinnova”, el primer número del Newsletter de Vetinnova.

Vet+i convoca la segunda edición del ‘Premio Isabel Mínguez Tudela a la Innovación en Sanidad Animal’

El plazo para la remisión de los trabajos estará abierto hasta el 15 de febrero. El galardón se entregará en el marco de la V Conferencia Anual de Vet+i.

Éxito del 1er Foro de Colaboración Público-Privada en Sanidad Animal, especie Por-cina, organizado conjuntamente por Vet+i y el INIA.

El Foro permitió dar a conocer las líneas de trabajo y las áreas de interés para es-tablecer futuras colaboraciones por parte de los centros públicos de investigación y de las empresas de la industria de la sanidad animal y otras organizaciones.

Vet+i en la constitución del nuevo Comité de Disponibilidad de Medicamentos de la AEMPS

Durante la reunión de constitución del Comité, Vet+i, dio traslado de las iniciativas que desde la Plataforma se han llevado en esta materia y que fueron valoradas muy positivamente por parte de los representantes de la AEMPS.

Se celebra la X Reunión del Consejo Gestor de Vet+i

Se valoraron positivamente los resultados de las actividades realizadas así como las actuaciones puestas en marcha.

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/vet+i-convoca-la-segunda-edicion-del-premio-isabel-minguez-tudela-a-la-innovacion-en-sanidad-animal_1777_14_1657_0_1_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/eventos/jornada-aportando-valor-a-la-empresa-incorporacion-de-talento-e-incentivos-fiscales-en-i+d+i_1774_15_1654_0_1_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/vet+i-crea-el-newsletter-de-vetinnova_1775_14_1655_0_1_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/eventos/ii-edicion-foro-transfiere_1758_15_1638_0_1_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/exito-del-1er-foro-de-colaboracion-publico-privada-en-sanidad-animal-especie-porcina-organizado-conjuntamente-por-vet+i-y-el-inia_1688_14_1571_0_2_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/vet+i-en-la-constitucion-del-nuevo-comite-de-disponibilidad-de-medicamentos-de-la-aemps_1668_14_1552_0_2_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/se-celebra-la-x-reunion-del-consejo-gestor-de-vet+i_1760_14_1640_0_1_in.html

24

Noticias

Vet+i asiste a una Jornada organizada por la Plataforma Tecnológica Europea para la Sanidad Animal Global (ETPGAH) en BruselasCon este tipo de Jornadas, Vet+i cumple uno de sus objetivos, referentes a la co-ordinación con la Plataforma Tecnológica Europea para la Sanidad Animal Global (ETPGAH) y las Plataformas Tecnológicas Nacionales de Sanidad Animal del resto de los Estados miembros.

Vet+i asiste al Acto de presentación del Foro Transfiere 2013

Vet+i participará en la segunda edición del “Foro Transfiere” cuyo objetivo es fomentar la transferencia y cooperación entre el ámbito científico y el sector em-presarial, objetivos en consonancia con la filosofía de la Plataforma.

41

Vet+i asiste al III Ciclo de Conferencias del MAGRAMA: ‘Modelos societarios para la colaboración público-privada en el horizonte nacional y europeo’.

Se presentaron las novedades de los nuevos mecanismos financieros para fomen-tar la colaboración público-privada en el marco de Horizonte 2020 y PAC.por medio de las patentes.

Vet+i participa en una reunión de trabajo del MINECO sobre Plataformas Tecnoló-gicas

Se abordaron temas de interés para la Plataformas Tecnológicas, como la convo-catoria INNPACTO 2012, ALINNSA y la nueva Estrategia de Ciencia y Tecnología y de Innovación, entre otros aspectos.

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/vet+i-participa-en-una-reunion-de-trabajo-del-mineco-sobre-plataformas-tecnologicas_1670_14_1554_0_2_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/vet+i-asiste-al-acto-de-presentacion-del-foro-transfiere-2013_1711_14_1594_0_1_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/vet+i-asiste-a-una-jornada-organizada-por-la-plataforma-tecnologica-europea-para-la-sanidad-animal-global-etpgah-en-bruselas_1693_14_1576_0_2_in.html

http://www.vetmasi.es/plataforma-tecnologica-espanola-de-sanidad-animal/noticias/vet+i-asiste-al-iii-ciclo-de-conferencias-del-magrama-modelos-societarios-para-la-colaboracion-publico-privada-en-el-horizonte-nacional-y-europeo_1759_14_1639_0_1_in.html

Proyecto financiado por:

C/ San Agustín 15-1º Dcha.28014 Madrid

Tlfno: (+34) 91 369 21 34Fax: (+34) 91 369 39 67 [email protected]

www.vetmasi.es

http://www.vetmasi.es

4 trimestre 2012...ooiwa seika japan wo 2012152898 a1 20121115 intervet int bv nether-lands...

Documents